Cardiometabolic & Weight Management Clinical Trial Solutions | Medable

Obesity · Weight management

Move at the speed of GLP-1 demand

As cardiometabolic and weight loss pipelines expand, sponsors need to launch global studies in weeks, not months. Medable helps trials scale, move faster from FPI to database lock, and get the data that matters sooner.

Everything you need to keep trials moving and patients participating

Platform reach

2K+

Global cardiometabolic sites on the Medable platform

Participation

24K+

Participants enrolled across cardiometabolic programs

Global

52

Distinct countries reached

Localization

86

Distinct locales supported

Cut initial study build timelines to two weeks or less with a program-led approach.

.gif)

Establish your standard

Make the operational investment once. Define reusable study components, translations, and integrations as your enterprise standard.

Adapt and configure

Scale a single molecule across multiple indications with a reusable operational framework.

Accellerate delivery across program

From onboarding participants to data visualization, our platform delivers the flexibility and efficiency you need for today’s clinical research demands.

Built to match the momentum of cardiometabolic

35x

faster first-time eCOA build vs. manual, with AI-assisted configuration and localization

50%

reduction in initial study build time — roughly 80 hours saved per study

10–20 wks

reduction in country go-lives by running translations in parallel for simultaneous global launch

Tools for clinical monitoring to keep your trials moving as fast as you do

Medable’s AI helps your team process more data, faster, with human oversight and audit controls built in.

AI-powered eCOA

eCOA configuration and accelerated localization for global deployment with participant and caregiver-friendly design to maintain high adherence.

Intelligent Consent

AI-powered eConsent and TeleVisit that streamline consent creation, review, and deployment in one participant app.

Monitoring Agent

Automate routine monitoring work so CRAs can focus on risks, sites, and patient safety.

Study Oversight Agent

Gain real-time visibility into study risk, vendor performance, and CRA performance across both individual studies and the broader portfolio.

We have successfully completed the study with an impressive dosing compliance rate of 94.5%. To put this into perspective, our previous Sleep Apnea study had a compliance rate of 85–87%. This remarkable improvement is a testament to our strong partnership...
TA Leader - Sleep Apnea Study

How a Top-10 Pharma standardized weight management trials and beat FPI by six weeks

Learn how a top-10 pharmaceutical company partnered with Medable to standardize a complex global weight management program spanning 70+ sites, accelerate study startup, improve the participant and site experience, and achieve First Patient In (FPI) six weeks ahead of schedule.

Frequently asked questions

How fast can a cardiometabolic study go live?

With reusable program assets, initial build drops to 1–2 weeks and a 4-week path to operational readiness before FPI. AI-assisted build and parallel translation compress global go-live.

How do you keep long-duration weight-management patients engaged?

A BYOD-friendly app unifies eCOA, eConsent, and TeleVisit with smart reminders and branching logic, sustaining 95% participant adherence across global studies.

Can the platform scale across an expanding GLP-1 portfolio?

Yes. Reusable frameworks, an asset catalog, and consistent operational deployment let you design once and scale across cohorts, master protocols, and adaptive programs.

What does Operational AI handle?

Agentic AI assists eCOA configuration and localization, automates high-volume eTMF filing, and surfaces enrollment, compliance, and safety signals early, always human-in-the-loop.